CagriSema-style escalation starts at 0.25 mg per week with semaglutide and steps up every 4 weeks (0.5, 1.0, 1.7, 2.4 mg) over 16 weeks
Lipotropic injections containing methionine, inositol, choline, and B-vitamins support fat metabolism
In May 2025, Aon released the first phase of a US study of GLP-1 medications for diabetes and weight management
IGF1 is a primary mediator of GH activity and directly influences muscle hypertrophy, protein synthesis, and nutrient partitioning (Yakar et al., Endocrinology )
Your provider monitors your tolerance, weight loss progress, and any adverse effects at each step
Licensed weight loss medicines with similar mechanisms semaglutide 2.4 mg (Wegovy) and tirzepatide (Mounjaro) both list alopecia in their UK SmPCs